PRIFTIN is a rifamycin antimycobacterial drug indicated in patients 12 years of age and older for the treatment of active pulmonary tuberculosis (TB) caused by Mycobacterium tuberculosis in combination with one or more anti-tuberculosis (anti-TB) drugs to which the isolate is susceptible. (1.1) * PRIFTIN is indicated for the treatment of latent tuberculosis infection (LTBI) caused by M.tuberculosis in combination with isoniazid in patients 2 years of age and older at high risk of progression to TB disease.
Document Date
Tuesday, May 31, 2022